Search results
Alison Lawton (born May 29, 1970) is a Canadian social venture philanthropist, social advocate, and business investor.
Alison Lawton is the founder and president of Mindset Venture Group, a company that invests in early-stage businesses and social ventures. She has a diverse portfolio of investments in technology, consumer, and real estate sectors, and is also involved in global health and social impact initiatives.
Alison Lawton most recently served as Kaleido’s Chief Executive Officer, President and as a member of the Board of Directors since August 2018, after initially joining the company as President and Chief Operating Officer in December 2017.
- Chair
- Magenta Therapeutics, Magenta Therapeutics
Alison Lawton - Founder and Executive Director. As a social venture philanthropist, Alison founded Mindset Social Innovation Foundation in 2006 and has focused her work around global health challenges and scaling social enterprises.
4 days ago · Alison Lawton is a biopharma executive with over 30 years of experience in the industry. She serves on the board of Dianthus Therapeutics, ProQR, X4 and Aeglea, and was the former CEO of Kaleido Biosciences.
BlueRock is a biotechnology company that develops cell therapies for various diseases. Alison Lawton is not mentioned on the web page, which introduces the executive team, board of directors, scientific advisors, and collaborators of BlueRock.
Jan 19, 2021 · Alison Lawton, a biopharma industry veteran with experience in drug development and commercialization, has been appointed to the Board of Directors of SwanBio Therapeutics, a gene therapy company. SwanBio is advancing AAV-based therapies for neurological conditions.
